NOVAVAX INC — Director's Dealing 2020

Dec 16, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2020-12-14

Reporting Person: Herrmann John A III (EVP, Chief Legal Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-14	Stock Option (Right to Buy)	$129.70	A	12700	Acquired	2030-12-14	Common Stock (12700)	Direct
2020-12-14	Restricted Stock Units	$	A	6300	Acquired		Common Stock (6300)	Direct

Footnotes

F1: Twenty-five percent (25%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), will vest on the first anniversary of the December 14, 2020 grant date (the "Grant Date"), and the remaining seventy-five percent (75%) of the shares will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment through such vesting date.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F3: One-third (1/3) of the RSUs subject to this grant under the Company's Plan will vest on each of the first three (3) anniversaries of the Grant Date, subject to continued employment through each such vesting date.